Key result
Inhibition of myoglobin-mediated NO degradation by carbon monoxide impaired myocardial contractility in iNOS-overexpressing hearts (78.2% vs 96.7% of baseline; P<0.005).
Myoglobin serves as an important cytoplasmic buffer of iNOS-derived NO, protecting myocardial contractility and energy state in hearts overexpressing iNOS.
Myoglobin may buffer iNOS-derived NO to preserve contractility; animal data leave open human relevance.
Elevated cardiac levels of nitric oxide (NO) generated by inducible nitric oxide synthase (iNOS) have been implicated in the development of heart failure. The surprisingly benign phenotype of recently generated mice with cardiac-specific iNOS overexpression (TGiNOS) provided the rationale to investigate whether NO scavenging by oxymyoglobin (MbO2) yielding nitrate and metmyoglobin (metMb) is involved in preservation of myocardial function in TGiNOS mice. 1H nuclear magnetic resonance (NMR) spectroscopy was used to monitor changes of cardiac myoglobin (Mb) metabolism in isolated hearts of wild-type (WT) and TGiNOS mice. NO formation by iNOS resulted in a significant decrease of the MbO2 signal and a concomitantly emerging metMb signal in spectra of TGiNOS hearts only (DeltaMbO2: -46.3+/-38.4 micromol/kg, DeltametMb: +41.4+/-17.6 micromol/kg, n=6; P<0.05) leaving contractility and energetics unaffected. Inhibition of the Mb-mediated NO degradation by carbon monoxide (20%) led to a deterioration of myocardial contractility in TGiNOS hearts (left ventricular developed pressure: 78.2+/-8.2% versus 96.7+/-4.6% of baseline, n=6; P<0.005), which was associated with a profound pertubation of cardiac energy state as assessed by 31P NMR spectroscopy (eg, phosphocreatine: 13.3+/-1.3 mmol/L (TGiNOS) versus 15.9+/-0.7 mmol/L (WT), n=6; P<0.005). These alterations could be fully antagonized by the NOS inhibitor S-ethylisothiourea. Our findings demonstrate that myoglobin serves as an important cytoplasmic buffer of iNOS-derived NO, which determines the functional consequences of iNOS overexpression.
No takes yet. Share an insight, caveat, or question.
Wunderlich et al. (2003) studied iNOS overexpression. Carbon monoxide vs. Baseline was evaluated on Left ventricular developed pressure (% of baseline) (p=<0.005). Inhibition of myoglobin-mediated NO degradation by carbon monoxide impaired myocardial contractility in iNOS-overexpressing hearts (78.2% vs 96.7% of baseline; P<0.005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: